• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

启动华法林治疗:5毫克与10毫克对比。

Initiating warfarin therapy: 5 mg versus 10 mg.

作者信息

Eckhoff Courtney D, Didomenico Robert J, Shapiro Nancy L

机构信息

Department of Pharmacy Practice, University of Illinois at Chicago, 833 S. Wood St, Chicago, IL 60612-7230, USA.

出版信息

Ann Pharmacother. 2004 Dec;38(12):2115-21. doi: 10.1345/aph.1E083. Epub 2004 Nov 2.

DOI:10.1345/aph.1E083
PMID:15522981
Abstract

OBJECTIVE

To review the literature investigating initial dosing of warfarin at 5 or 10 mg for treatment of acute venous thromboembolism.

DATA SOURCES

Articles were identified through searches of MEDLINE (1966-December 2003) using the key words warfarin, oral anticoagulation, warfarin dose, warfarin initiation, venous thromboembolism, and anticoagulation. Additional references were located through review of the bibliographies of the articles cited.

STUDY SELECTION AND DATA EXTRACTION

Studies of the initial dosing of warfarin at 5 or 10 mg were evaluated and relevant information was included, as were those that identified known factors that influence the maintenance dose of warfarin.

DATA SYNTHESIS

For the treatment of acute venous thromboembolism, warfarin dosing is often provider dependent. Until recently, studies suggested that 5 mg initiation was as effective as 10 mg, without increasing the risk of bleeding. However, the most recent study comparing a 5- versus 10-mg initial dosing nomogram supports an initial dose of 10 mg. These results should be interpreted with caution, however, since patients at high risk for bleeding were excluded from the study. Several patient-specific factors will affect the maintenance dose, guiding clinicians to start with lower (<5 mg) or higher (>5 mg) doses.

CONCLUSIONS

Although recent evidence supports a 10-mg initiation nomogram, clinicians should consider patient-specific factors prior to deciding an initial warfarin dose. If a 10-mg loading dose is utilized, strict compliance with the protocol is necessary.

摘要

目的

回顾关于华法林初始剂量为5毫克或10毫克用于治疗急性静脉血栓栓塞症的文献研究。

数据来源

通过检索MEDLINE(1966年至2003年12月),使用关键词华法林、口服抗凝、华法林剂量、华法林起始、静脉血栓栓塞症和抗凝来识别文章。通过查阅所引用文章的参考文献找到其他相关文献。

研究选择与数据提取

对华法林初始剂量为5毫克或10毫克的研究进行评估,并纳入相关信息,以及那些识别出影响华法林维持剂量的已知因素的研究。

数据综合

对于急性静脉血栓栓塞症的治疗,华法林的剂量通常取决于医疗服务提供者。直到最近,研究表明起始剂量为5毫克与10毫克的效果相同,且不会增加出血风险。然而,最近一项比较5毫克与10毫克初始剂量方案的研究支持初始剂量为10毫克。不过,这些结果应谨慎解读,因为该研究排除了出血高风险患者。几个患者特异性因素会影响维持剂量,指导临床医生从较低(<5毫克)或较高(>5毫克)剂量开始。

结论

尽管最近的证据支持10毫克起始剂量方案,但临床医生在决定华法林初始剂量之前应考虑患者特异性因素。如果采用10毫克的负荷剂量,必须严格遵守方案。

相似文献

1
Initiating warfarin therapy: 5 mg versus 10 mg.启动华法林治疗:5毫克与10毫克对比。
Ann Pharmacother. 2004 Dec;38(12):2115-21. doi: 10.1345/aph.1E083. Epub 2004 Nov 2.
2
Comparison of a single end point to determine optimal initial warfarin dosing (5 mg versus 10 mg) for venous thromboembolism.
Am J Cardiol. 2006 Aug 15;98(4):535-7. doi: 10.1016/j.amjcard.2006.02.063. Epub 2006 Jun 28.
3
A 10 mg warfarin initiation nomogram is safe and effective in outpatients starting oral anticoagulant therapy for venous thromboembolism.对于开始口服抗凝治疗静脉血栓栓塞症的门诊患者,10毫克华法林起始剂量列线图是安全有效的。
Thromb Res. 2009 Jul;124(3):275-80. doi: 10.1016/j.thromres.2008.12.001. Epub 2009 Jan 19.
4
Extended anticoagulation for a first episode of idiopathic venous thromboembolism.首次特发性静脉血栓栓塞症的延长抗凝治疗
J Fam Pract. 1999 Aug;48(8):579-80.
5
[Current issues in the initial phase of warfarin therapy].[华法林治疗初始阶段的当前问题]
Recenti Prog Med. 2005 Dec;96(12):612-5.
6
Anticoagulation period in idiopathic venous thromboembolism. How long is enough?特发性静脉血栓栓塞症的抗凝期。多长时间足够?
Saudi Med J. 2004 Jul;25(7):848-51.
7
Genetic testing for warfarin therapy initiation.
Ann Pharmacother. 2008 Sep;42(9):1298-303. doi: 10.1345/aph.1L127. Epub 2008 Aug 5.
8
Duration of anticoagulant therapy after initial idiopathic venous thromboembolism.初发性特发性静脉血栓栓塞症后抗凝治疗的持续时间。
Ann Pharmacother. 2003 Oct;37(10):1489-96. doi: 10.1345/aph.1C486.
9
Practical application of the 10-mg warfarin initiation nomogram.10毫克华法林起始剂量列线图的实际应用
Blood Coagul Fibrinolysis. 2009 Sep;20(6):403-8. doi: 10.1097/MBC.0b013e32832b184d.
10
Long-term anticoagulation prophylaxis following acute thromboembolism.
Dis Mon. 2005 Feb-Mar;51(2-3):158-65. doi: 10.1016/j.disamonth.2005.03.011.

引用本文的文献

1
Warfarin initiation nomograms for venous thromboembolism.静脉血栓栓塞症的华法林起始剂量计算图。
Cochrane Database Syst Rev. 2016 Jan 29;2016(1):CD007699. doi: 10.1002/14651858.CD007699.pub3.
2
Warfarin and calcific uremic arteriolopathy.华法林与钙化性尿毒症小动脉病
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.06.2008.0126. Epub 2009 Dec 3.
3
Inpatient warfarin management: pharmacist management using a detailed dosing protocol.住院患者华法林管理:采用详细剂量方案的药师管理。
J Thromb Thrombolysis. 2012 Feb;33(2):178-84. doi: 10.1007/s11239-011-0655-9.
4
Drug-related problems identified in post-discharge medication reviews for patients taking warfarin.华法林治疗患者出院后药物治疗评估中发现的与药物相关问题。
Int J Clin Pharm. 2011 Aug;33(4):621-6. doi: 10.1007/s11096-011-9515-0. Epub 2011 May 19.
5
Oral anticoagulation in the hospital: analysis of patients at risk.医院内的口服抗凝治疗:风险患者分析。
J Thromb Thrombolysis. 2011 Jan;31(1):22-6. doi: 10.1007/s11239-010-0473-5.
6
Clarification of terminology in medication errors: definitions and classification.用药错误术语的澄清:定义与分类
Drug Saf. 2006;29(11):1011-22. doi: 10.2165/00002018-200629110-00001.